Metopeart 50 Tablet ER
Marketer
Accuren BioPharma
Salt Composition
Metoprolol Succinate (50mg)
Overview Metopeart 50 Tablet ER
CardioBeta 50 Extended-Release tablets are a beta-blocker medication used to manage hypertension, angina pectoris, and cardiac arrhythmias. This medication also aids in migraine prevention and reduces the risk of future strokes and myocardial infarctions. CardioBeta 50 ER may be administered independently or as part of a combination therapy regimen. Dosage and frequency are tailored to the specific condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefits may not be apparent for several weeks, and continuous use may be necessary. Discontinuing treatment can exacerbate underlying conditions, even in the absence of noticeable symptoms. Common, generally mild and transient, adverse effects include fatigue, cephalgia, depressive symptoms, diarrhea, skin rashes, bradycardia, dizziness, and nausea. Less frequently, shortness of breath or hypotension may occur. Gradual dose escalation minimizes adverse reactions. Report any persistent or bothersome side effects to your physician. Prior to commencing therapy, disclose any hepatic impairment. This medication is contraindicated in individuals with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals require medical consultation before use. A physician's assessment is essential to determine suitability. Regular blood pressure monitoring is recommended to assess treatment effectiveness. Alcohol consumption should be limited due to potential exacerbation of certain side effects.
Uses of Metopeart 50 Tablet ER
Management of angina pectoris|Cardiac arrhythmia management|Myocardial infarction prophylaxis|Hypertension therapy|Migraine prevention
Major Benefits of Metopeart 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Metopeart 50 Tablet ER whole; do not chew, crush, or break it. This medication can be taken with or without food, but consistent timing is recommended. For optimal absorption, avoid consuming Metopeart 50 Tablet ER with meals high in fat, including those containing olive oil, nuts (like Brazil nuts), dark chocolate, butter, or significant amounts of meat.
Common Side effects of Metopeart 50 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metopeart 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metopeart 50 Tablet ER. Ingest the tablet whole; do not chew, crush, or divide it. This medication can be taken with or without food, but consistency in timing is recommended. Limit consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and fatty meats, while using Metopeart 50 Tablet ER.
How Metopeart 50 Tablet ER works:
CardioSlow ER 50mg tablets are extended-release beta-blockers with a targeted cardiac action. They reduce heart rate and enhance the heart's pumping efficiency, improving circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metopeart 50 Tablet ER and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metopeart 50mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metopeart 50mg tablets are likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Extended-release Metopeart 50mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.
KidneySAFE IF PRESCRIBED
Metopeart 50 Extended-Release tablets can be used safely by individuals with kidney impairment; no dosage modification is necessary.
LiverCAUTION
Patients with hepatic impairment should use Metopeart 50 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Metopeart 50 Tablet ER :
Should you forget a Metopeart 50 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metopeart 50 Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Type of Therapy | Heart |


